González-Blázquez R.; Alcalá M.; Cárdenas-Rebollo J.M.; Viana M.; Steckelings U.M.; Boisvert W.A.; Unger T.; Fernández-Alfonso M.S.; Somoza B.; Gil-Ortega M.
(2021)
The aim of the present study was to evaluate the effect of Compound 21 (C21), a selective AT2R agonist, on the prevention of endothelial dysfunction, extracellular matrix (ECM) remodeling and arterial stiffness associated ...